Affymax (OTCMKTS:AFFY) Stock Price Breaks Above Two Hundred Day Moving Average – What’s Next?

Shares of Affymax Inc. (OTCMKTS:AFFY) passed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $0.00 and traded as high as $0.0017. Affymax shares last traded at $0.0017, with a volume of 3,200 shares trading hands.

Affymax Stock Up 2,347.1%

About Affymax

Affymax, Inc was a biotechnology company focused on developing novel therapies for serious medical conditions. The company used drug-discovery and molecular engineering technologies to identify and advance pharmaceutical candidates, with an emphasis on treatments for hematology and related disorders.

Affymax’s principal product was peginesatide, an anemia treatment marketed in the United States under the brand name Omontys. The U.S. Food and Drug Administration approved Omontys in 2012 for the treatment of anemia associated with chronic kidney disease.